Literature DB >> 21289475

Differential virulence of Candida albicans and C. dubliniensis: A role for Tor1 kinase?

Derek J Sullivan1, Gary P Moran.   

Abstract

Candida albicans and Candida dubliniensis are two very closely related species of pathogenic yeast. C. albicans is the most prevalent species in the human gastrointestinal tract and is responsible for far more opportunistic infections in comparison with C. dubliniensis. This disparity is likely to be due to the reduced ability of C. dubliniensis to undergo the yeast to hypha transition, a change in morphology that plays an important role in C. albicans virulence. We have recently shown that hypha formation by C. dubliniensis is specifically repressed by nutrients at alkaline pH. In this article, we present new data showing that this can be partly reversed by treatment with rapamycin, an inhibitor of the nutrient sensing kinase Tor1 (Target Of Rapamycin). We also provide a speculative model to describe why C. albicans filaments more efficiently in nutrient rich environments, citing recently described data on Mds3, a pH responsive regulator of Tor1 kinase activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289475     DOI: 10.4161/viru.2.1.15002

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  13 in total

1.  Oma1 Links Mitochondrial Protein Quality Control and TOR Signaling To Modulate Physiological Plasticity and Cellular Stress Responses.

Authors:  Iryna Bohovych; Stavroula Kastora; Sara Christianson; Danelle Topil; Heejeong Kim; Teresa Fangman; You J Zhou; Antoni Barrientos; Jaekwon Lee; Alistair J P Brown; Oleh Khalimonchuk
Journal:  Mol Cell Biol       Date:  2016-08-12       Impact factor: 4.272

2.  Usefulness of the Non-conventional Caenorhabditis elegans Model to Assess Candida Virulence.

Authors:  Marcelo Ortega-Riveros; Iker De-la-Pinta; Cristina Marcos-Arias; Guillermo Ezpeleta; Guillermo Quindós; Elena Eraso
Journal:  Mycopathologia       Date:  2017-05-18       Impact factor: 2.574

Review 3.  Potential Targets for Antifungal Drug Discovery Based on Growth and Virulence in Candida albicans.

Authors:  Xiuyun Li; Yinglong Hou; Longtao Yue; Shuyuan Liu; Juan Du; Shujuan Sun
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

4.  Comparative evolution of morphological regulatory functions in Candida species.

Authors:  Erika Lackey; Geethanjali Vipulanandan; Delma S Childers; David Kadosh
Journal:  Eukaryot Cell       Date:  2013-08-02

5.  Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom.

Authors:  Andrew M Borman; Adrien Szekely; Chistopher J Linton; Michael D Palmer; Phillipa Brown; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2013-01-09       Impact factor: 5.948

6.  Candida albicans versus Candida dubliniensis: Why Is C. albicans More Pathogenic?

Authors:  Gary P Moran; David C Coleman; Derek J Sullivan
Journal:  Int J Microbiol       Date:  2011-09-04

7.  Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates.

Authors:  Juliana C Junqueira; Beth B Fuchs; Maged Muhammed; Jeffrey J Coleman; Jamal M A H Suleiman; Simone F G Vilela; Anna C B P Costa; Vanessa M C Rasteiro; Antonio O C Jorge; Eleftherios Mylonakis
Journal:  BMC Microbiol       Date:  2011-11-04       Impact factor: 3.605

8.  Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.

Authors:  Ziauddin Khan; Suhail Ahmad; Leena Joseph; Rachel Chandy
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

9.  Candida albicans exhibits enhanced alkaline and temperature induction of Efg1-regulated transcripts relative to Candida dubliniensis.

Authors:  Nicole Caplice; Gary P Moran
Journal:  Genom Data       Date:  2015-09-07

10.  Candida species Rewired Hyphae Developmental Programs for Chlamydospore Formation.

Authors:  Bettina Böttcher; Christine Pöllath; Peter Staib; Bernhard Hube; Sascha Brunke
Journal:  Front Microbiol       Date:  2016-10-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.